# NIH Reporter #11316739

Process Validation and Commercialization of SelfWrap, a Bioabsorbable Wrap to Improve Dialysis Access Outcomes

**Recipient:** VENOSTENT, INC.

**Award Amount:** $500,000.00
**Ceiling:** $500,000.00

**Awarded:** September 11, 2026

**Identifier:** 11316739

Award for process validation and commercialization of a bioabsorbable wrap to improve dialysis access outcomes, funded by NIH with FDA Breakthrough Device Designation.

### Description

The project involves process validation and commercialization activities for a bioabsorbable wrap to improve dialysis access outcomes. The funding is provided by the NIH, with a Breakthrough Device Designation from FDA in 2022. The project aims to revolutionize vascular surgery and improve patient outcomes.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11316739)